Sort
46,585 grants matching “heart failure”
Nanochelation Therapies for Iron Overload Disorders
$543,043Jonghan Kim · University Of Massachusetts Lowell · R01 · FY2021 · HL
Regulation of Histone Deacetylases by mAKAP Signalosomes
$543,013Michael S Kapiloff · Stanford University · R01 · FY2019 · HL
Project 1: Understanding normal tissue toxicity to identify patients most likely to benefit from proton therapy.
$542,984Harald Paganetti · Massachusetts General Hospital · P01 · FY2024 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$542,980David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
A New Framework for Understanding the Mechanisms of Diastolic Dysfunction
$542,962Daniel B Ennis · Palo Alto Veterans Instit For Research · R01 · FY2019 · HL
MicroRNA as mediators of angiogenesis & ischemic myocardial repair
$542,796Meifeng Xu · University Of Cincinnati · R01 · FY2012 · HL
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
$542,795Benzi M Kluger · University Of Colorado Denver · R01 · FY2019 · NR
Role of presympathetic neurons of the hindbrain in cardiovascular control
$542,756Stephen Abbott · University Of Virginia · R01 · FY2020 · HL
Role of presympathetic neurons of the hindbrain in cardiovascular control
$542,756Stephen Abbott · University Of Virginia · R01 · FY2021 · HL
Clinical Trials of Allogeneic Transplantation for Inherited Immune Deficiencies
$542,746Elizabeth Kang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Shear-Induced Hemostatic Dysfunction and Bleeding in CF-VAD Patients
$542,736Zhongjun Jon Wu · University Of Louisville · R01 · FY2015 · HL
The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
$542,731Wanpen Vongpatanasin · Ut Southwestern Medical Center · R01 · FY2015 · HL
Novel Insights into the Mechanistic Role of Small Rho GTPase in Chronic Cardiac Fibrotic Remodeling
$542,663Weijia Luo · Texas A&M University Health Science Ctr · R01 · FY2025 · HL
Novel cardioskeletal myopathy associated with MYL2
$542,614Danuta Szczesna-Cordary · University Of Miami School Of Medicine · R01 · FY2015 · HL
Angiotensin-Converting Enzyme2 in Vascular Endothelial Function
$542,612Mohan K. Raizada · University Of Florida · R01 · FY2012 · HL
Action of SARS CoV2 in Human Brain Cultures
$542,592Ted M. Dawson · Johns Hopkins University · RF1 · FY2020 · AG
Molecular and Cellular Basis of Cardiovascular Disease
$542,499Shaun R. Coughlin · University Of California, San Francisco · T32 · FY2014 · HL
Myofilaments as regulators of heart function in disease
$542,491Joseph Mark Metzger · University Of Minnesota · R01 · FY2024 · HL
Molecular Determinants of MG53 in Heart Structure and Function
$542,448Long-Sheng Song · University Of Iowa · R01 · FY2022 · HL
Protein Kinase Novel 2 (PKN2) in heart
$542,381Ju Chen · University Of California, San Diego · R01 · FY2023 · HL
DFU Clinical Research Unit
$542,357Rodica Pop-Busui · University Of Michigan At Ann Arbor · U01 · FY2021 · DK
2/2 Self-directed mobile adaptive coping skills intervention to improve psychological distress symptoms among cardiorespiratory failure survivors: the Blueprint RCT
$542,336Cynthia D Morris · Oregon Health & Science University · U24 · FY2025 · HL
ImpleMEntation of a Digital-first care deLiverY model for heart failure in Uganda (MEDLY Uganda)
$542,296Jeremy Ian Schwartz · Yale University · R01 · FY2024 · HL
Distinct Pathways of VPF/VEGF Receptors
$542,279Debabrata Mukhopadhyay · Mayo Clinic Jacksonville · R01 · FY2019 · HL
Project 1 - Endogenous and Exogenous Mechanisms that Promote Myocardial Remuscularization
$542,257Jianyi Zhang · University Of Alabama At Birmingham · P01 · FY2024 · HL